Title: Rethooling the MRFF: Putting Health Equity at the Centre of Australian Research Funding
Introduction
Australia’s research agenda is undergoing a quiet but consequential pivot. The Medical Research Future Fund (MRFF), long associated with funding scientific discovery, is increasingly judged not only by methodological excellence but also by whether funded work closes persistent health gaps. In practice this means prioritising projects that demonstrably benefit First Nations peoples, people living in rural and remote areas, and culturally and linguistically diverse communities – because discoveries only count when they reach and improve the lives of the most disadvantaged.
From discovery to delivery: a new funding logic
Historically, grant success relied heavily on novelty, translational promise and commercial pathways. Today, MRFF assessments routinely balance rigor with reach: panels expect clear evidence that projects will be co-produced with affected communities, have realistic pathways into clinical and primary care settings, and include measurable equity outcomes. Applicants are increasingly required to show how their work will be taken up in the real world – not just published in journals.
What funders now require
Contemporary application criteria are reshaping project design. Common expectations include:
– Genuine co-design: documented partnerships and governance arrangements with community organisations or representative bodies, especially Indigenous-led groups.
– Equity baselining: explicit analysis of current disparities by region, ethnicity, language and socioeconomic status so progress can be measured.
– Time-bound impact goals: staged, measurable targets (for example, uplift in screening participation or reductions in preventable admissions within a defined period).
– Accountability and transparency: commitments to report disaggregated outcomes publicly so communities and funders can track impact.
Priority portfolios and the types of projects getting traction
Recent rounds have tilted discretionary funding toward interventions that combine cultural leadership, scaleability and digital enablement. Examples now favoured by reviewers include:
– First Nations-governed clinical and prevention programs: initiatives led by Aboriginal Community Controlled Health Organisations that embed cultural governance into trial design and service delivery.
– Rural access innovations: outreach clinics, locally based specialist outreach, and telehealth-enabled pathways that cut travel costs and reduce the need for patients to relocate for care.
– High-need urban precinct work: place-based, data-driven screening and chronic disease management in suburbs with concentrated disadvantage.
– Language-access and cultural supports: multilingual digital tools, in-consultation interpreter services and culturally tailored recruitment strategies to improve participation and retention for non-English-speaking communities.
These priorities reflect a simple shift: investment is now judged by whether new knowledge or technologies can be implemented equitably – not solely by scientific novelty.
Illustrative delivery models showing early promise
Several approaches are emerging as practical, scalable ways to close gaps:
– Mobile multidisciplinary teams that bring specialists, allied health and diagnostic services to towns and remote communities, coordinated with local GPs.
– Indigenous health navigators and locally trained community clinicians who bridge cultural and clinical systems, increasing trust and follow‑through.
– Hybrid care hubs combining virtual specialist input with periodic onsite clinics to stabilise long‑term conditions without repeated hospital transfers.
– Multilingual self‑management apps and community digital literacy programs that support chronic disease control across language groups.
– Community paramedicine and other task‑shifted models where non-traditional workforce roles deliver urgent and follow-up care closer to home.
Think of the change this way: it’s no longer sufficient to “invent” an effective intervention; the funder now asks how that intervention will be delivered, accepted and sustained in communities that have historically been missed by mainstream services.
Policy levers to institutionalise equity
To make equity an enduring feature of research funding, policymakers and funders are exploring several concrete tools:
– Mandatory equity indicators attached to major grants (for instance, targets for reductions in avoidable hospitalisations or increases in screening uptake within priority populations).
– Linked, de-identified datasets that allow outcomes to be tracked across primary care, hospitals and community services by subgroup.
– Public-facing dashboards reporting progress by region, Indigenous status and socioeconomic quintile to increase transparency and accountability.
– Multi‑year funding commitments and contractual incentives (and, where appropriate, penalties) tied to measurable improvements rather than project outputs alone.
Experts have discussed multi-year ambitions such as reducing avoidable admissions by 15-25% in targeted high-need areas, and raising screening and vaccination rates among under-served groups within three to five years as plausible benchmarks for impact-focused funding.
Practical challenges and mitigations
Embedding equity across research funding systems is complex. Key obstacles include:
– Fragmented data and privacy constraints that make timely, subgroup-level analysis difficult. Mitigation: investment in secure data linkage infrastructure and standardised reporting formats.
– Short funding cycles that undermine long‑term implementation work. Mitigation: more multi-year grants and staged milestone-based payments.
– Limited capacity in smaller community organisations to manage large grants or complex evaluations. Mitigation: built-in leadership funding, capacity-building grants and partnership models that pair community organisations with research institutions.
– The need for independent verification and benchmarking to maintain public trust in reported outcomes. Mitigation: independent audit mechanisms and third-party evaluation clauses in funding agreements.
What success looks like
If the MRFF’s reorientation takes hold, success will be measured by measurable narrowing of gaps rather than publication counts alone. Tangible indicators to watch include:
– Increased primary care engagement and continuity in priority communities.
– Reductions in specialist wait times for rural and remote patients.
– Fewer preventable hospital admissions in targeted postcodes.
– Higher screening and vaccination coverage among under‑served groups.
– Publicly available, disaggregated outcome data that community leaders can use to hold systems to account.
Practical examples and recent context
The rapid expansion of telehealth during the COVID‑19 pandemic demonstrated how quickly service delivery can adapt when policy, funding and clinical practice align; maintaining that momentum in ways that reduce inequities is a current focus. Meanwhile, several community-led pilots – from Indigenous‑governed screening programs to place-based chronic disease initiatives in disadvantaged suburbs – are being trialled with MRFF support, offering early lessons about the importance of local leadership, flexible funding and measurable milestones.
Conclusion
The MRFF’s move toward health equity is more than a tweak to grant guidelines: it represents a redefinition of impact. Funders are now asking for credible plans that deliver benefits to those historically left behind, and are structuring grants to reward evidence of real-world change. For researchers, health services and policymakers the message is clear: scientific excellence will be judged not only by what we discover, but by who benefits and how quickly those benefits are realised.